Literature DB >> 9443350

Huntington's disease.

M S Haddad1, J L Cummings.   

Abstract

Huntington's disease is a genetically inherited degenerative neuropsychiatric disorder, characterized by motor alterations, including involuntary movements such as chorea, dementia and psychiatric disturbances. In this article, the authors review the clinical features of the disease. They also analyze some genetic and pathophysiologic aspects, that can help to improve our understanding of this disorder involving the basal ganglia.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9443350     DOI： 10.1016/s0193-953x(05)70345-2

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN： 0193-953X


  9 in total

Review 1.  The Tiny Drosophila Melanogaster for the Biggest Answers in Huntington's Disease.

Authors:  Abraham Rosas-Arellano; Argel Estrada-Mondragón; Ricardo Piña; Carola A Mantellero; Maite A Castro
Journal:  Int J Mol Sci       Date:  2018-08-14       Impact factor: 5.923

2.  Electroconvulsive shock ameliorates disease processes and extends survival in huntingtin mutant mice.

Authors:  Mohamed R Mughal; Akanksha Baharani; Srinivasulu Chigurupati; Tae Gen Son; Edmund Chen; Peter Yang; Eitan Okun; Thiruma Arumugam; Sic L Chan; Mark P Mattson
Journal:  Hum Mol Genet       Date:  2010-11-24       Impact factor: 6.150

3.  Preclinical Huntington's disease: compensatory brain responses during learning.

Authors:  Andrew Feigin; Maria-Felice Ghilardi; Chaorui Huang; Yilong Ma; Maren Carbon; Mark Guttman; Jane S Paulsen; Claude P Ghez; David Eidelberg
Journal:  Ann Neurol       Date:  2006-01       Impact factor: 10.422

4.  Altered excitatory and inhibitory inputs to striatal medium-sized spiny neurons and cortical pyramidal neurons in the Q175 mouse model of Huntington's disease.

Authors:  Tim Indersmitten; Conny H Tran; Carlos Cepeda; Michael S Levine
Journal:  J Neurophysiol       Date:  2015-02-11       Impact factor: 2.714

5.  Striatal Direct and Indirect Pathway Output Structures Are Differentially Altered in Mouse Models of Huntington's Disease.

Authors:  Joshua Barry; Garnik Akopian; Carlos Cepeda; Michael S Levine
Journal:  J Neurosci       Date:  2018-04-24       Impact factor: 6.167

Review 6.  Biological functions and potential therapeutic applications of huntingtin-associated protein 1: progress and prospects.

Authors:  X Zhao; A Chen; Z Wang; Xiao-Han Xu; Y Tao
Journal:  Clin Transl Oncol       Date:  2021-09-26       Impact factor: 3.405

7.  Differential changes to D1 and D2 medium spiny neurons in the 12-month-old Q175+/- mouse model of Huntington's Disease.

Authors:  Joseph W Goodliffe; Hanbing Song; Anastasia Rubakovic; Wayne Chang; Maria Medalla; Christina M Weaver; Jennifer I Luebke
Journal:  PLoS One       Date:  2018-08-17       Impact factor: 3.240

8.  Defining Utility Values for Chorea Health States in Patients with Huntington's Disease.

Authors:  Daniel O Claassen; Rajeev Ayyagari; Debbie Goldschmidt; Mo Zhou; Sam Leo; Rinat Ribalov
Journal:  Adv Ther       Date:  2022-02-23       Impact factor: 3.845

9.  ANN and Fuzzy Logic Based Model to Evaluate Huntington Disease Symptoms.

Authors:  Andrius Lauraitis; Rytis Maskeliūnas; Robertas Damaševičius
Journal:  J Healthc Eng       Date:  2018-03-11       Impact factor: 2.682
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.